Form 4 for SER Serina Therapeutics, Inc.
Accepted 2026-05-26 16:26:47 ET · period of report 2026-05-21 · accession 0001267490-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-26 16:26 | 2026-05-21+ | SER | WILSON KAREN J | Dir | P - Purchase | $1.85 | +20.0K | 20.0K | New | +$37.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-21 | P | A | 10,000 | $1.77 | 10,000 | D | — | — | (F1) The price reflects the weighted average purchase price of multiple transactions ranging from a low purchase price of $1.76 per share to a high purchase price of $1.79 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price. |
| 2 | Common | Common Stock | 2026-05-22 | P | A | 10,000 | $1.93 | 20,000 | D | — | — | (F2) The price reflects the weighted average purchase price of multiple transactions ranging from a low purchase price of $1.90 per share to a high purchase price of $1.95 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price. |